OBJECTIVE: Calculation of valid and detailed risks of cancer from, and up to, specific ages for inhabitants of the Netherlands. DESIGN: Secondary analyses of cancer incidence and mortality rates. METHOD: Gender and age-specific incidence rates of 56 different types of cancer were obtained from the Netherlands Cancer Registry. Gender and age-specific mortality rates were obtained from Statistics Netherlands. Using survival charts, risks of cancer were calculated from all ages and up to all ages, in steps of 5 years. The US National Cancer Institute's software programme DevCan was used for analyses. RESULTS: One out of every 2.3 newborn males (43.9%) and one out of every 2.6 newborn females (38.1%) in the Netherlands will develop cancer sometime during their life. The risk of developing cancer before the age of 80 is 35.9% for newborn males and 30.2% for newborn females. Women run the greatest risk of developing breast cancer (almost 13%). 50-year-old women have a risk of almost 3% of being diagnosed with breast cancer before the age of 60. Men have the greatest risk of a diagnosis of prostate cancer (almost 10%). The risk for a 50-year-old man of being diagnosed with prostate cancer within the subsequent 10 years however is less than 1%. CONCLUSION: Detailed rates of risks of cancer are useful for policy issues such as decisions to implement screening programmes, for public education, and for patient counselling, as in the field of clinical genetics. The routinely reported risks for newborns developing cancer before the age of 75 lack the necessary detail for such use.
OBJECTIVE: Calculation of valid and detailed risks of cancer from, and up to, specific ages for inhabitants of the Netherlands. DESIGN: Secondary analyses of cancer incidence and mortality rates. METHOD: Gender and age-specific incidence rates of 56 different types of cancer were obtained from the Netherlands Cancer Registry. Gender and age-specific mortality rates were obtained from Statistics Netherlands. Using survival charts, risks of cancer were calculated from all ages and up to all ages, in steps of 5 years. The US National Cancer Institute's software programme DevCan was used for analyses. RESULTS: One out of every 2.3 newborn males (43.9%) and one out of every 2.6 newborn females (38.1%) in the Netherlands will develop cancer sometime during their life. The risk of developing cancer before the age of 80 is 35.9% for newborn males and 30.2% for newborn females. Women run the greatest risk of developing breast cancer (almost 13%). 50-year-old women have a risk of almost 3% of being diagnosed with breast cancer before the age of 60. Men have the greatest risk of a diagnosis of prostate cancer (almost 10%). The risk for a 50-year-old man of being diagnosed with prostate cancer within the subsequent 10 years however is less than 1%. CONCLUSION: Detailed rates of risks of cancer are useful for policy issues such as decisions to implement screening programmes, for public education, and for patient counselling, as in the field of clinical genetics. The routinely reported risks for newborns developing cancer before the age of 75 lack the necessary detail for such use.
Authors: Mirjam P J Bogaarts; Brenda L Den Oudsten; Jan A Roukema; Johanna M G H Van Riel; Laurens V Beerepoot; Jolanda De Vries Journal: Support Care Cancer Date: 2011-08-24 Impact factor: 3.603
Authors: Marlies J E Kempers; Roland P Kuiper; Charlotte W Ockeloen; Pierre O Chappuis; Pierre Hutter; Nils Rahner; Hans K Schackert; Verena Steinke; Elke Holinski-Feder; Monika Morak; Matthias Kloor; Reinhard Büttner; Eugene T P Verwiel; J Han van Krieken; Iris D Nagtegaal; Monique Goossens; Rachel S van der Post; Renée C Niessen; Rolf H Sijmons; Irma Kluijt; Frans B L Hogervorst; Edward M Leter; Johan J P Gille; Cora M Aalfs; Egbert J W Redeker; Frederik J Hes; Carli M J Tops; Bernadette P M van Nesselrooij; Marielle E van Gijn; Encarna B Gómez García; Diana M Eccles; David J Bunyan; Sapna Syngal; Elena M Stoffel; Julie O Culver; Melanie R Palomares; Tracy Graham; Lea Velsher; Janos Papp; Edith Oláh; Tsun L Chan; Suet Y Leung; Ad Geurts van Kessel; Lambertus A L M Kiemeney; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg Journal: Lancet Oncol Date: 2010-12-08 Impact factor: 41.316
Authors: Merel L Kimman; Monique Mf Bloebaum; Carmen D Dirksen; Ruud Ma Houben; Philippe Lambin; Liesbeth J Boersma Journal: BMC Cancer Date: 2010-04-30 Impact factor: 4.430
Authors: Joost Nederend; Lucien Em Duijm; Adri C Voogd; Johanna H Groenewoud; Frits H Jansen; Marieke Wj Louwman Journal: Breast Cancer Res Date: 2012-01-09 Impact factor: 6.466
Authors: R S van der Post; L A Kiemeney; M J L Ligtenberg; J A Witjes; C A Hulsbergen-van de Kaa; D Bodmer; L Schaap; C M Kets; J H J M van Krieken; N Hoogerbrugge Journal: J Med Genet Date: 2010-07 Impact factor: 6.318
Authors: Pieter H van Baal; Peter M Engelfriet; Hendriek C Boshuizen; Jan van de Kassteele; Francois G Schellevis; Rudolf T Hoogenveen Journal: Popul Health Metr Date: 2011-09-01